Sanofi Sarclisa gains Chinese nod for treatment of adult patients with relapsed or refractory multiple myeloma Ruchika Sharma14 Jan 2025 1:30 PM ISTParis: Sanofi has announced that the National Medical Products Administration (NMPA) in China has approved Sarclisa, an anti-CD38 medicine,...
USFDA accepts for review application for GSK Blenrep combinations for multiple myeloma treatment Ruchika Sharma26 Nov 2024 5:52 PM ISTLondon: GSK plc has announced the US Food and Drug Administration (FDA) has accepted for review a Biologics License Application (BLA) for...
Pomalidomide Significantly Reduces Epistaxis Severity in HHT Patients, Study Finds Dr Riya Dave15 Oct 2024 8:15 AM ISTResearchers have found that the severity of epistaxis significantly diminishes in affected patients with hereditary hemorrhagic telangiectasia (HHT)...
Cancer drug may be repurposed for hereditary bleeding disorder, reveals clinical trial Dr. Kamal Kant Kohli20 Sept 2024 4:00 AM ISTA drug approved for treating the blood cancer multiple myeloma may offer a safe and effective way to reduce the risk of severe nosebleeds from a rare...
Natco Pharma, others sued in US for generic cancer drug Ruchika Sharma8 Sept 2023 4:13 PM ISTHyderabad: Natco Pharma on Friday said the company and other drug makers have been named defendants in an antitrust lawsuit regarding a generic...
Janssen seeks USFDA nod for Carvykti for relapsed or refractory multiple myeloma Ruchika Sharma8 Jun 2023 12:30 PM ISTRaritan: The Janssen Pharmaceutical Companies of Johnson & Johnson has announced the submission of a supplemental Biologics License...
Natco Pharma unveils first generic version of Pomalyst capsules in Australia Ruchika Sharma9 Nov 2022 4:01 PM ISTPomalidomide is prescribed for treatment of Multiple Myeloma and Kaposi Sarcoma.
Setback: GSK blood cancer drug Blenrep fails main goal of superiority trial Ruchika Sharma8 Nov 2022 12:30 PM ISTBlenrep is an antibody drug conjugate comprising a humanised BCMA monoclonal antibody conjugated to the cytotoxic agent auristatin F via non-cleavable...
Sanofi Multiple Myeloma Drug Sarclisa Gets European Nod Ruchika Sharma5 Jun 2020 9:30 AM ISTSarclisa is a monoclonal antibody (mAb) that binds to a specific epitope on the CD38 receptor of MM cells
